Home › Neoplasms by Histologic Type › Georgia › Atlanta
Neoplasms by Histologic Type clinical trials in Atlanta, GA
5 studies for Neoplasms by Histologic Type are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- Emory University Hospital, Atlanta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Emory Healthcare - The Emory Clinic, Atlanta
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- Winship Cancer Institute of Emory University, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Winship Cancer Institute - Emory University, Atlanta
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
RecruitingPhase 1
- Northside Hospital, Atlanta
Neoplasms by Histologic Type trials in other cities
- Boston, MA5 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
- Chicago, IL4 studies
- Baldwin Park, CA3 studies
- Dallas, TX3 studies
- Clifton, NJ3 studies
- Nashville, TN3 studies
- San Francisco, CA3 studies
- New York City, NY3 studies
- St. Louis, MO3 studies
- Tampa, FL3 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Multiple Myeloma41 studies
- Breast Cancer41 studies
- Prostate Cancer32 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Obesity25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.